Pacira BioSciences, Inc. - stock earnings
Stock symbol PCRX is outdated, potentially delisted? Maybe it is available on other exchange?
PCRX Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 1, 2024 AfterMarket | - / 0.6387000000 | - | - / 169.2 million | - |
PCRX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -19.5 million USD | 160.3 million USD |
| 2022Q4 | -10.1 million USD | 172.0 million USD |
| 2022Q3 | -693000 USD | 167.5 million USD |
| 2022Q2 | 19.9 million USD | 169.4 million USD |
| 2022Q1 | 6.8 million USD | 158.0 million USD |
| 2021Q4 | -5.1 million USD | 159.2 million USD |
| 2021Q3 | 17.7 million USD | 127.7 million USD |
| 2021Q2 | 19.1 million USD | 135.6 million USD |
| 2021Q1 | 10.4 million USD | 119.0 million USD |
| 2020Q4 | 14.5 million USD | 131.0 million USD |
| 2020Q3 | 130.1 million USD | 117.5 million USD |
PCRX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | 15.9 million USD | 666.8 million USD |
| 2021 | 42.0 million USD | 541.5 million USD |
| 2020 | 145.5 million USD | 429.6 million USD |
| 2019 | -11.0 million USD | 421.0 million USD |
| 2018 | -471000 USD | 337.3 million USD |
| 2017 | -42.6 million USD | 286.6 million USD |
PCRX
Price: $28.29
52 week price:
Earnings Per Share: 3.95 USD
P/E Ratio: 119.03
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 331700
Ebitda: 936000Market Capitalization: 2.0 billion